๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Radiation therapy following resection of non-small cell bronchogenic carcinoma

โœ Scribed by Jerry D. Slater; Nancy A. Ellerbroek; H. Thomas Barkley Jr.; Clifton Mountain; Mary Jane Oswald; Jack A. Roth; Lester J. Peters

Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
783 KB
Volume
20
Category
Article
ISSN
0360-3016

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Resection of stage III non-small cell lu
Resection of stage III non-small cell lung cancer following induction therapy
โœ Valerie W. Rusch ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer ๐ŸŒ English โš– 779 KB

Approximately 25%-30% of all patients with non-small cell lung cancer (NSCLC) present with stage III tumors. Except for specific subsets, these tumors are not usually amenable to complete surgical resection and are associated with a 5-year survival of 10% or less. Because patients with stage III NSC

Benefits of polychemotherapy in advanced
Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma
โœ Yvon Cormier; Dollard Bergeron; Jacques La Forge; Michel Lavandier; Marcien Four ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 377 KB ๐Ÿ‘ 2 views

The benefits of polychemotherapy in advanced (Stage 111) non-small-cell bronchogenic carcinoma remain uncertain. In attempt to answer the important question whether treatment improves well-being and survival in these patients, we did a prospective, randomized, single-blind study to compare polychemo